Fermenta Biotech Ltd. (FERMENTA) Share Price Within 2% of 52-Week High
- August 10, 2026
- Posted by: Harsh Piplani
- Category: News
Fermenta Biotech Ltd. Share Price stands at Rs 567, and the stock is trading within 2% of its 52-week high. The company’s market capitalisation is Rs 1,646.81 crore.
Fermenta Biotech Ltd. Share Price is at Rs 567, and the stock is trading within 2% of its 52-week high, putting the counter back on the radar for investors tracking momentum alongside valuation and business quality. With a market capitalisation of Rs 1,646.81 crore, Fermenta Biotech Ltd. sits in the mid-sized listed healthcare space, and that size alone can make moves near a one-year peak worth monitoring.
The verified data from the Univest screener confirms the price event and identifies Fermenta Biotech Ltd. Share Price as being close to its yearly high at the qualification time of 10 August 2026 at 10:30:37 AM IST. The event-time last traded price was Rs 567. The supplied data confirms the proximity event, though it does not establish a company-specific catalyst for today’s attention.
For investors following Fermenta Biotech Ltd. Share Price Today and broader Fermenta Biotech Ltd. Stock News, the significance lies in the combination of price strength, a moderate valuation relative to some peers, and a profitability profile that looks more measured than many stocks in the Pharmaceuticals & Drugs space. That makes this a useful setup for deeper stock analysis rather than a headline-only move.
Fermenta Biotech Ltd. Share Price Today: Within 2% of 52-Week High
| Metric | Value |
|---|---|
| LTP at 2% Qualification | Rs 567 |
| Market Capitalisation | Rs 1,646.81 crore |
| 52-Week High Position | Trading within 2% of its 52-week high |
Fermenta Biotech Ltd. (FERMENTA) traded at Rs 567. Reported volume was 7,756.
Fermenta Biotech Ltd. Share Price Today at Rs 567 places the stock within striking distance of its one-year peak, according to the Univest screener. The event was qualified at an exact last traded price of Rs 567, and that is the key confirmed price level for this near-52-week-high screen. Because the stock is trading within 2% of its 52-week high, it naturally attracts added attention from market participants who track relative strength and watchlists built around price leadership.
What matters here is not just the screen result, but the context around it. Fermenta Biotech Ltd. Share Price is being assessed in a market-cap bracket of Rs 1,646.81 crore, which is well above the same-industry median market capitalisation of Rs 142.3 crore and the same-industry average of Rs 481.12 crore. That means the move is happening in a company that is already larger than a substantial portion of the Pharmaceuticals & Drugs universe used for the benchmark.
The data supplied for Fermenta Biotech Ltd. Share Price does not establish a company-specific reason behind today’s attention, but the proximity to a 52-week high is itself enough to put the stock into active discussion. Investors often revisit such names to check whether price strength is being matched by earnings power, return ratios and relative valuation. In this case, the next step is to move from price action into the underlying financial picture.
Fermenta Biotech Ltd. (FERMENTA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,646.81 crore |
| P/E Ratio | 22.95x |
| P/B Ratio | 4.08x |
| ROE | 4.27% |
| ROCE | 7.5% |
| EPS | Rs 24.38 |
| Book Value Per Share | Rs 137.06 |
| Dividend Yield | 0.67% |
Fermenta Biotech Ltd. was valued at a P/E ratio of 22.95x, a P/B ratio of 4.08x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of 4.27% and ROCE of 7.5%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Per-share and shareholder-return metrics included EPS of Rs 24.38, book value per share of Rs 137.06, dividend yield of 0.67%. Dividend yield is a current or historical ratio and does not guarantee future distributions.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 22.95x |
| Benchmark Median P/E | 18.11x |
| Benchmark Average P/E | 60.26x |
| Benchmark P/E Range | 0x to 3,417.8x |
| Company P/B Ratio | 4.08x |
| Benchmark Median P/B | 1.82x |
| Company ROE | 4.27% |
| Benchmark Median ROE | 9.93% |
| Company ROCE | 7.5% |
| Benchmark Median ROCE | 12.96% |
| Company Market Capitalisation | Rs 1,646.81 crore |
| Benchmark Median Market Cap | Rs 142.3 crore |
Fermenta Biotech Ltd. (FERMENTA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Fermenta Biotech Ltd. (FERMENTA) has a P/E ratio of 22.95x, which is above the benchmark median of 18.11x, a difference of +26.73%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Fermenta Biotech Ltd. (FERMENTA) has a ROE of 4.27%, which is below the benchmark median of 9.93%, a difference of -57%. Fermenta Biotech Ltd. (FERMENTA) has a ROCE of 7.5%, which is below the benchmark median of 12.96%, a difference of -42.13%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Jagsonpal Pharmaceuticals Ltd. | JAGSNPHARM | 1,533.19 | 33.71 | 6.11 | 15.7 | 19.43 |
| Amrutanjan Health Care Ltd. | AMRUTANJAN | 1,511.88 | 26.1 | 4.08 | 32.69 | 44 |
| Windlas Biotech Ltd. | WINDLAS | 1,823.52 | 27.44 | 3.55 | 12.87 | 14.88 |
| Ind-Swift Laboratories Ltd. | INDSWFTLAB | 1,986.64 | 47.97 | 1.35 | -0.78 | 8.31 |
| Indoco Remedies Ltd. | INDOCO | 2,045.45 | 363.31 | 2.04 | 12.85 | 15.67 |
Fermenta Biotech Ltd. (FERMENTA) has a P/E ratio of 22.95x compared with the displayed peer median of 33.71x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 4.27% compares with a peer median of 12.87% across the companies shown in the table. ROCE stood at 7.5% versus the displayed peer median of 15.67%, providing a capital-efficiency comparison. Fermenta Biotech Ltd. (FERMENTA) has a market capitalisation of Rs 1,646.81 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Fermenta Biotech Ltd.
- Fermenta Biotech Ltd. Share Price is at Rs 567 and the stock is trading within 2% of its 52-week high, which is a widely tracked momentum screen.
- The company has a market capitalisation of Rs 1,646.81 crore, placing it well above the same-industry median of Rs 142.3 crore and average of Rs 481.12 crore.
- Valuation looks mixed: P/E is 22.95 versus the industry median of 18.11 and average of 60.26, while P/B is 4.08 versus the median of 1.82.
- Profitability remains positive, with EPS of Rs 24.38, ROE of 4.27, ROCE of 7.5 and dividend yield of 0.67.
- Peer data shows Fermenta Biotech Ltd. Share Price trades at a lower P/E than several supplied industry peers, but with lower return ratios than many of them.
- Univest data confirms the price event, making the stock relevant for investors tracking 52-week levels, valuation and sector positioning together.
About Fermenta Biotech Ltd.
Fermenta Biotech Ltd. is classified in the Healthcare sector and the Pharmaceuticals & Drugs industry in the supplied dataset. That places the company within a large listed industry set used for benchmark comparison in this article. Fermenta Biotech Ltd. Share Price is therefore being evaluated not as a standalone move, but against other pharmaceutical and healthcare businesses with comparable market disclosures.
Based on the verified data available here, the stock is part of an industry where valuation and return ratios can vary sharply across companies. The same-industry benchmark spans 139 companies, while the broader sector count is 201. Fermenta’s market capitalisation of Rs 1,646.81 crore positions it as a meaningfully larger listed player than the industry median company by size. On Univest, investors typically track such names not only for price movement, but also for how fundamentals and peer metrics evolve around important price levels such as the 52-week high.
Track Fermenta Biotech Ltd. Share Price on Univest
Use Fermenta Biotech Ltd. (FERMENTA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors tracking Fermenta Biotech Ltd. Share Price can use Univest to follow live price movement, 52-week levels, valuation ratios, profitability metrics, sector comparisons and peer positioning in one place. Univest also helps users monitor Fermenta Biotech Ltd. Share Price Today alongside market capitalisation, P/E, P/B, ROE, ROCE, EPS, book value and dividend yield. For investors who prefer structured stock analysis, Univest makes it easier to compare Fermenta Biotech Ltd. Share Price with industry benchmarks and other listed pharmaceutical names without relying only on headline-driven market chatter.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Fermenta Biotech Ltd. Share Price today?
Ans. Fermenta Biotech Ltd. Share Price was Rs 567 at the event qualification time on 10 August 2026 at 10:30:37 AM IST. The Univest screener identified the stock as trading within 2% of its 52-week high.
Why is Fermenta Biotech Ltd. Share Price in focus today?
Ans. Fermenta Biotech Ltd. Share Price is in focus because the verified Univest screen shows the stock trading within 2% of its 52-week high. The supplied data confirms the price event, though it does not establish a company-specific catalyst.
What is the market capitalisation of Fermenta Biotech Ltd.?
Ans. Fermenta Biotech Ltd. has a market capitalisation of Rs 1,646.81 crore. That is well above the same-industry median of Rs 142.3 crore and higher than the same-industry average of Rs 481.12 crore in the supplied benchmark.
How is Fermenta Biotech Ltd. valued on P/E and P/B?
Ans. Fermenta Biotech Ltd. trades at a P/E of 22.95 and a P/B of 4.08. Its P/E is above the industry median of 18.11, while its P/B is above both the industry median of 1.82 and average of 2.89.
What do Fermenta Biotech Ltd.'s ROE and ROCE show?
Ans. Fermenta Biotech Ltd. reports ROE of 4.27 and ROCE of 7.5. Both metrics are positive, but they are below the same-industry medians of 9.93 for ROE and 12.96 for ROCE in the supplied comparison set.
What are the EPS, book value and dividend yield of Fermenta Biotech Ltd.?
Ans. Fermenta Biotech Ltd. has EPS of Rs 24.38, book value per share of Rs 137.06 and dividend yield of 0.67. These figures provide context on earnings, accounting net worth and historical payout relative to the current share price.
Which sector and industry does Fermenta Biotech Ltd. belong to?
Ans. Fermenta Biotech Ltd. belongs to the Healthcare sector and Pharmaceuticals & Drugs industry. The sector comparison in this article uses a same-industry benchmark covering 139 companies, with a broader sector universe of 201 companies.
How does Fermenta Biotech Ltd. compare with selected peers on valuation?
Ans. Fermenta Biotech Ltd. trades at a P/E of 22.95, lower than Jagsonpal, Amrutanjan, Windlas, Ind-Swift and Indoco in the supplied peer set. Its P/B of 4.08 matches Amrutanjan, but exceeds several other listed peers.
How does Fermenta Biotech Ltd. compare with selected peers on profitability?
Ans. Fermenta Biotech Ltd. has ROE of 4.27 and ROCE of 7.5. Those figures are below Jagsonpal, Amrutanjan, Windlas and Indoco on both metrics, while its ROE is above Ind-Swift’s negative ROE of -0.78.
What can investors track on Univest for Fermenta Biotech Ltd.?
Ans. On Univest, investors can track Fermenta Biotech Ltd. Share Price, 52-week levels, valuation ratios, profitability metrics, market capitalisation and peer comparisons. That helps place the stock’s near-52-week-high position in a broader analytical context.
